Cancer in HIV patients

Area of Science:

• Oncology
• Virology
• Immunology

Background:

• This study investigated cancer incidence patterns following the initiation of antiretroviral therapy (ART) in HIV-infected individuals.
• The analysis included 11,485 participants across eight U.S. HIV clinical cohorts from 1996-2011, with a median CD4 count of 202 cells/mm³ at ART start.

Discussion:

• Cancer risk varies based on CD4 count at ART initiation and duration of therapy.
• Age at ART initiation and longer treatment duration are associated with increased incidence of non-AIDS-defining cancers.
• Viral-associated cancers, including those linked to hepatitis B/C, Epstein-Barr virus, and human papillomavirus (HPV), were specifically assessed.

Key Insights:

• Initiating ART with low CD4 counts is linked to higher risks of certain cancers.
• The incidence of other cancers increases over time on ART, correlating with patient age.
• Distinct patterns exist for AIDS-defining, non-AIDS-defining, and viral-associated cancers post-ART initiation.

Outlook:

• Understanding these evolving cancer risks is crucial for long-term HIV management.
• Further research can refine risk stratification and personalized cancer screening protocols for individuals on ART.
• This knowledge aids in developing targeted prevention and treatment strategies for HIV-associated malignancies.